Literature DB >> 1846524

Aggressive surgical intervention in N2 non-small cell cancer of the lung.

Y Watanabe1, J Shimizu, M Oda, Y Hayashi, S Watanabe, Y Tatsuzawa, T Iwa, M Suzuki, T Takashima.   

Abstract

An aggressive attitude toward surgical treatment was taken in patients with N2 non-small cell lung cancer in the past 10 years. Computed tomographic scanning was employed in the diagnosis of N2 disease, and had a true-positive rate of 57%. Among patients with N2 disease detected by computed tomographic scanning, surgical intervention was attempted except for those with unresectable disease. Of 190 patients with clinical N2 disease, 115 underwent surgical exploration: 9 patients had only an exploratory thoracotomy, 53 patients underwent a curative operation, and 53 had a noncurative operation. The overall 5-year survival rate of these patients was 16% and that of curatively resected patients was 20%. There were 47 patients whose N2 disease was not recognized before operation. The 5-year survival rate of this group was 20% overall and 33% in curatively resected cases. The overall 5-year survival rate of patients with N2 disease who underwent resection (106 with clinical N2 disease and 47 with clinically unrecognized N2 disease) was 17%, and that of the 84 patients undergoing curative operations was 24%. An aggressive attitude toward surgical intervention can be advocated for patients with N2 disease on the basis of our present results.

Entities:  

Mesh:

Year:  1991        PMID: 1846524     DOI: 10.1016/0003-4975(91)90797-t

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  15 in total

1.  [Postoperative radiotherapy in curatively resected non-small-cell bronchial carcinoma].

Authors:  H T Klages; M Stuschke
Journal:  Strahlenther Onkol       Date:  1999-03       Impact factor: 3.621

2.  Prognostic significance of persistent mediastinal metastasis following induction therapy in large (> or = 2 cm) N2 or N3 non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Mitsunori Ohta; Hajime Maeda; Shin-ichi Takeda; Hiroshi Hirano; Yoshitomo Okumura; Hiroki Asada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-04

Review 3.  The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors:  W Theuer; O Selawry; K Karrer
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

4.  The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography.

Authors:  M Sasaki; Y Ichiya; Y Kuwabara; Y Akashi; T Yoshida; T Fukumura; S Murayama; T Ishida; K Sugio; K Masuda
Journal:  Eur J Nucl Med       Date:  1996-07

Review 5.  Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.

Authors:  R Milroy; F Macbeth
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

6.  Anatomic basis of lymphatic spread of lung carcinoma to the mediastinum: anatomo-clinical correlations.

Authors:  M Riquet; D Manac'h; P Dupont; A Dujon; G Hidden; B Debesse
Journal:  Surg Radiol Anat       Date:  1994       Impact factor: 1.246

7.  The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer.

Authors:  Masaki Goto; Masahito Naito; Koichi Saruwatari; Kakeru Hisakane; Motohiro Kojima; Satoshi Fujii; Takeshi Kuwata; Atsushi Ochiai; Shogo Nomura; Keiju Aokage; Tomoyuki Hishida; Junji Yoshida; Kohei Yokoi; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-17       Impact factor: 4.553

8.  Factors affecting long term survival following resection for lung cancer.

Authors:  K al-Kattan; E Sepsas; E R Townsend; S W Fountain
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

9.  Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases.

Authors:  T Fukuse; T Hirata; H Naiki; S Hitomi; H Wada
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

10.  A clinical analysis of small-sized lung cancer with advanced disease.

Authors:  J Shimizu; Y Hayashi; M Oda; S Murakami; Y Arano; K Morita; K Kobayashi; K Ietsugu; Y Watanabe
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.